As an additional test to determine whether the AN18 antibody was impacting IFNγ signaling within the tumor, we compared the ratio of IRF1:IFNγ transcripts, since IRF1 expression is in part dependent on the presence of IFNγ (Figure 3D). Here, IRF1 is linked to neoplasm.